Koyfin Home > Directory > Health Care > Amag Pharmaceuticals > EBITDA Margin

Amag Pharmaceuticals EBITDA Margin Chart (AMAG)

Amag Pharmaceuticals annual/quarterly EBITDA Margin from 2010 to 2020. An EBITDA margin is a measurement of a company's earnings before interest, taxes, depreciation, and amortization as a percentage of its total revenue.
  • Amag Pharmaceuticals EBITDA Margin for the quarter ending June 06, 2020 was $-24m a 34.87% decrease of -8m year over year
  • Amag Pharmaceuticals EBITDA Margin for the last 12 months ending June 06, 2020 was $-25m a -26.29% increase of 7m year over year
  • Amag Pharmaceuticals Annual EBITDA Margin for 2019 was $-35m a 159.13% decrease of -56m from 2018
  • Amag Pharmaceuticals Annual EBITDA Margin for 2018 was $21m a -61.95% decrease of -13m from 2017
  • Amag Pharmaceuticals Annual EBITDA Margin for 2017 was $34m a -56.36% decrease of -19m from 2016
Other Margins & Efficiency Metrics:
  • Amag Pharmaceuticals Return on Capital % for the quarter ending September 09, 2018 was -1.36 a 8.15% decrease of -0.11 year over year
  • Amag Pharmaceuticals Return on Equity % for the quarter ending September 09, 2018 was -34.75 a 105.01% decrease of -36.49 year over year
View Chart On Koyfin

Quarterly AMAG EBITDA Margin Data

06/2020$-24m
03/2020$-24m
12/2019$-46m
09/2019$-16m
06/2019$-43m
03/2019$-46m
12/2018$-18m
09/2018$20m
06/2018$40m
03/2018$25m

Annual AMAG EBITDA Margin Data

2019$-35m
2018$21m
2017$34m
2016$52m
2015$48m
2014$12m
2013$-7m
2012$-13m
2011$-113m
2010$-118m